Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The International Registry for Alzheimer's Disease and Other Dementias (InRAD): An International Registry Observational Study Dedicated to Evaluating Outcomes Data in Alzheimer's Disease

NCT07213700 is registered in ClinicalTrials.gov with Stichting International Registry for Alzheimer's Disease and other Dementias Foundation as lead sponsor.

NCT NCT07213700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07213700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The International Registry for Alzheimer's Disease and Other Dementias (InRAD): An International Registry Observational Study Dedicated to Evaluating Outcomes Data in Alzheimer's Disease
Lead sponsor
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Phase
Observational
Overall status
Recruiting
Start date
March 30, 2026
Completion date
January 31, 2036
Enrollment
50,000 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease(ad), mild cognitive impairment (mci), non-alzheimer degenerative dementia, subjective cognitive decline (scd)